4basebio PLC

4basebio PLC

4BB · London Exchange

4basebio PLC (4BB) is a Biotechnology company in the Healthcare sector, listed on London Exchange. This page provides the complete earnings calendar, dividend schedule, and financial data for 4basebio PLC in 2026. The next earnings report is expected on September 25, 2026.

Earnings calendar

Next earnings date

25 Sep 2026

In 36 days

EPS estimate

-0.79

Revenue estimate

699.2K

Past earnings

22 May 2026
EPS actual
-0.79 (0.0%)
estimate -0.79
Revenue actual
699.2K (0.0%)
estimate 699.2K
Price reaction
1d
+2.37%
5d
-2.41%
30d
+4.37%
Sign in to view returns
Beat Miss usd

Dividend calendar

No dividend history available.

EPS (Earnings Per Share)

Revenue

Company profile

4basebio PLC engages in the design, development, manufacturing, and supply of synthetic DNA and RNA products, and targeted non-viral vector solutions in the United States, Europe, and internationally. The company provides research kits, bulk enzymes, and other products, as well as licensing services; and AVV manufacturing services. It serves biotech, pharma, and contract development and manufacturing organization customers. The company was formerly known as 4basebio UK Societas and changed its name to 4basebio PLC in July 2021. 4basebio PLC was incorporated in 2020 and is based in Cambridge, United Kingdom.

Sector
Healthcare
Industry
Biotechnology
Country
Great Britain
Exchange
London Exchange
CEO
Amy Jo Walker
Employees
101
IPO date
17 Feb 2021
ISIN
GB00BMCLYF79
Website
4basebio.com

Frequently asked questions

When does 4basebio PLC (4BB) next report earnings?

4basebio PLC (4BB) is scheduled to report earnings on September 25, 2026.

What was 4basebio PLC's most recent earnings date?

4basebio PLC (4BB) last reported earnings on May 22, 2026.

Where is 4basebio PLC stock listed?

4basebio PLC (4BB) is listed on London Exchange.